Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 31 -40 of 129 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	MDMA-Assisted Therapy in People With Anxiety Related to Advanced Stage Cancer				Phase II				63,384-2 NCT00252174
	Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-Cancer Modalities				Phase II				397231205-HMO-CTIL NCT00348842
	Randomized Phase II Study for Patients With Previously Treated Advanced Urothelial Cancer				Phase II				FER-GU-004 NCT00350025
	Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy				Phase II				2005407-01H OTT 05-03, NCT00350688
	Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium				Phase II				MSKCC-06081 NCT00397488
	Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma				Phase II				UMCC 2005.145 NCT00393796
	Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor				Phase II				CINJ-3330 NCT00161187
	Pazopanib in Treating Patients With Metastatic Urothelial Cancer				Phase II				MAYO-MC0553 7661, MC0553, NCT00471536
	Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma				Phase II				0609001823 NCT00461851
	Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction				Phase II				MDA-2005-0839 MDA-2005-0939, 2005-0839, 7341, NCT00478361


					< Previous 1 2 3 4 5 6 7 Next >

| | | | | | | |

A Service of the National Cancer Institute